ADMA BIOLOGICS, INC. Quarterly Operating Lease, Payments in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Adma Biologics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q2 2020 to Q3 2024.
  • Adma Biologics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $600K, unchanged year-over-year.
  • Adma Biologics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $2.4M, a 4.35% increase year-over-year.
  • Adma Biologics, Inc. annual Operating Lease, Payments for 2023 was $2.4M, a 33.3% increase from 2022.
  • Adma Biologics, Inc. annual Operating Lease, Payments for 2022 was $1.8M, a 28.6% increase from 2021.
  • Adma Biologics, Inc. annual Operating Lease, Payments for 2021 was $1.4M, a 180% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.4M $600K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $2.4M $600K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.4M $600K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.4M $600K +$100K +20% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $2.3M $600K +$100K +20% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.2M $600K +$200K +50% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2M $600K +$200K +50% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.8M $500K +$200K +66.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $1.6M $500K +$200K +66.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $1.4M $400K -$200K -33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.6M $400K +$200K +100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $1.4M $300K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $300K +$200K +200% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $600K +$500K +500% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $200K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $100K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $100K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.